Abstract
The constant increase of life expectancy is associated with major ageing of developed populations. This indicates that the new century will have one of most epidemic progressions of cardiovascular, cancer and inflammatory diseases. The high challenge for medical research is to compress such morbidity. In these conditions, invertebrates have demonstrated to be truly useful models in drug discovery for such ageing diseases. The last decade, drug discovery in leeches has opened the gate of new molecules to treat emphysema, coagulation, inflammation, dermitis and cancer. Also other invertebrates such as insects, which evolved from the annelids, harvest potential interesting molecules, such as serine protease inhibitors that can be exploited by the medical industry.
Keywords: trypsin, chymotrypsin inhibitors, insects, gut leeches, serine protease inhibitors, hirudo medicinalis, therostasin
Current Pharmaceutical Design
Title: Trypsin and Chymotrypsin Inhibitors in Insects and Gut Leeches
Volume: 8 Issue: 7
Author(s): Liliane Schoofs, Elke Clynen and Michel Salzet
Affiliation:
Keywords: trypsin, chymotrypsin inhibitors, insects, gut leeches, serine protease inhibitors, hirudo medicinalis, therostasin
Abstract: The constant increase of life expectancy is associated with major ageing of developed populations. This indicates that the new century will have one of most epidemic progressions of cardiovascular, cancer and inflammatory diseases. The high challenge for medical research is to compress such morbidity. In these conditions, invertebrates have demonstrated to be truly useful models in drug discovery for such ageing diseases. The last decade, drug discovery in leeches has opened the gate of new molecules to treat emphysema, coagulation, inflammation, dermitis and cancer. Also other invertebrates such as insects, which evolved from the annelids, harvest potential interesting molecules, such as serine protease inhibitors that can be exploited by the medical industry.
Export Options
About this article
Cite this article as:
Schoofs Liliane, Clynen Elke and Salzet Michel, Trypsin and Chymotrypsin Inhibitors in Insects and Gut Leeches, Current Pharmaceutical Design 2002; 8 (7) . https://dx.doi.org/10.2174/1381612023395718
DOI https://dx.doi.org/10.2174/1381612023395718 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations
Current Pharmaceutical Design Role of Vitamins in Human Health and Nutrition: Sources and Morbidity
Current Nutrition & Food Science Hypercoagulability and Nephrotic Syndrome
Current Vascular Pharmacology Pyrazolines: A Biological Review
Mini-Reviews in Medicinal Chemistry Do We Need More Research on Platelet Function in South Asian Immigrants?
Inflammation & Allergy - Drug Targets (Discontinued) Periodontitis and Redox Status: A Review
Current Pharmaceutical Design Opioids and Mechanical Ventilation
Current Drug Targets The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Dietary Polyphenols for Prostate Cancer Therapy
Current Bioactive Compounds Retracted: Potential Health Benefits of Broccoli- A Chemico-Biological Overview
Mini-Reviews in Medicinal Chemistry Bacterial Urease and its Role in Long-Lasting Human Diseases
Current Protein & Peptide Science CYP Epoxygenase Derived EETs: From Cardiovascular Protection to Human Cancer Therapy
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Mood Disorders and General Medical Comorbidities: Shared Biology and Novel Therapeutic Targets)
Current Molecular Medicine Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease
Current Neuropharmacology Adverse Drug Reactions in a Pulmonary Teaching Hospital: Incidence, Pattern, Seriousness, and Preventability
Current Drug Safety Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Prospects for Discovering the Secondary Metabolites of <i>Cordyceps</i> Sensu Lato by the Integrated Strategy
Medicinal Chemistry Anti-Inflammatory Intervention for Acute Liver Failure: Recent Patents and Future Targets
Recent Patents on Biomarkers Molecular Imaging of Vascular Thrombosis
Current Molecular Imaging (Discontinued)